Teva misses on Q3 profit and revenue - Globes
Teva misses on Q3 profit and revenue - Globes
Teva reaches $225m Texas opioid settlement - Globes
Teva reaches opioid settlement with West Virginia - Globes
Teva: 48 US states agree opioid settlement - Globes
Teva expands sustainability notes issue to $5b - Globes
Teva Original Universal Sandals | Anthropologie
Amazon.com | Teva Men's Katavi 2 Sandal, Black Olive, 7 | Sport Sandals & Slides
Teva shed 37% of Israel workforce in two years - Globes
Teva Pharmaceutical to pay $523-million to New York State as it looks to move past opioid lawsuits - The Globe and Mail
Teva faces lawsuit from Israel over unpaid Copaxone royalties
Teva boosted as FDA delays generic Copaxone - Globes
Teva's stunning list of cuts targets 14K jobs, $3B in costs and plants around the globe | Fierce Pharma
Amazon.com | Teva Men's Hurricane XLT2 Sandal, Borderless Brown Multi, 8 | Sport Sandals & Slides
Teva keeps 2020 guidance unchanged despite virus crisis - Globes
Teva Pharmaceuticals to cut 25 percent of jobs in huge reshaping - The Boston Globe
Analysts urge M&A for Teva - Globes
Teva's new CEO: There's an opportunity to return to growth - Globes
Teva Footwear: Who We Are | Teva®
Teva shed 37% of Israel workforce in two years - Globes
Teva recalls US-made drugs following contamination fears - The Boston Globe
Little chance of Teva CEO seeing share price bonus - Globes
Teva Footwear: Who We Are | Teva®
Teva reports heavy losses, sees minimal 2023 growth - Globes
Teva spin-off 89bio files for $70m Wall Street IPO - Globes
With $40 million pay, Teva breaks from custom for turnaround - The Boston Globe
